Tuesday, March 21, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
-
Associate Professor
Department of Internal Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
The Ohio State University College of Medicine
Columbus, Ohio
Lab Chief
NIH Lasker Clinical Tenure Track Investigator and NIH Distinguished Scholar
Laboratory of Applied Precision Omics
Division of Intramural Research
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, Maryland
Assistant Professor
Lung Transplantation Program
Pulmonary and Critical Care Medicine
The Johns Hopkins Hospital
Johns Hopkins School of Medicine
Baltimore, Maryland
Participation by Dr Agbor-Enoh does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins
Hospital and Health System.
Professor/Clinical Medical Director
Lung Transplantation
Director
Pulmonary Hypertension Center
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™
This activity is intended for pulmonologists, transplant surgeons, and other HCPs who work with patients who have received a lung transplant.
The goal of this activity is to improve knowledge around current standards for acute and chronic rejection monitoring and increase understanding of the clinical trial data on donor-derived cell-free DNA (dd-cfDNA) for transplant rejection monitoring.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
-
Associate Professor
Department of Internal Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
The Ohio State University College of Medicine
Columbus, Ohio
Lab Chief
NIH Lasker Clinical Tenure Track Investigator and NIH Distinguished Scholar
Laboratory of Applied Precision Omics
Division of Intramural Research
National Heart, Lung, and Blood Institute
National Institutes of Health
Bethesda, Maryland
Assistant Professor
Lung Transplantation Program
Pulmonary and Critical Care Medicine
The Johns Hopkins Hospital
Johns Hopkins School of Medicine
Baltimore, Maryland
Participation by Dr Agbor-Enoh does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins
Hospital and Health System.
Professor/Clinical Medical Director
Lung Transplantation
Director
Pulmonary Hypertension Center
The University of Texas Health Science Center at San Antonio
San Antonio, Texas
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME Released: 4/22/2022
Valid for credit through: 4/22/2023
processing....
